Literature DB >> 10879677

The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat.

R Hernández-Tristán1, C Arévalo, S Canals, M L Leret.   

Abstract

The aim of the present study was to evaluate the effects of delta9-tetrahydrocannabinol (delta9-THC) on exploratory behaviour and memory, independent of its locomotor suppressive effects. Dopamine (DA) and noradrenaline (NA) contents were determined in the areas of the brain directly related to such behaviours (hippocampus, striatum and amygdala). An acute dose of delta9-THC led to a decrease in exploratory parameters and motor activity during the holeboard test. The radial arm maze was used to evaluate the effects of this cannabinoid substance on memory. Animals treated with delta9-THC committed more errors in the maze test compared to control, particularly when the retention process was put to test. Furthermore, treatment with delta9-THC led to reduced NA contents in the hippocampus and increased DA contents in the amygdala, without changes in the striatum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10879677     DOI: 10.1007/BF03179772

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  22 in total

1.  Effect of acute delta9-THC treatment on hypothalamic catecholamines and sexual behaviour in male rats.

Authors:  R Hernández-Tristán; C Arévalo
Journal:  J Physiol Biochem       Date:  1999-03       Impact factor: 4.158

2.  The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

Authors:  J Romero; R de Miguel; J A Ramos; J J Fernández-Ruiz
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

3.  Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice.

Authors:  A Chakrabarti; J E Ekuta; E S Onaivi
Journal:  Brain Res Bull       Date:  1998       Impact factor: 4.077

4.  Pharmacological characterization of cannabinoids in the elevated plus maze.

Authors:  E S Onaivi; M R Green; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1990-06       Impact factor: 4.030

5.  An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.

Authors:  M Navarro; J J Fernández-Ruiz; R de Miguel; M L Hernández; M Cebeira; J A Ramos
Journal:  Behav Brain Res       Date:  1993-10-21       Impact factor: 3.332

6.  Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.

Authors:  M C Sañudo-Peña; S L Patrick; R L Patrick; J M Walker
Journal:  Neurosci Lett       Date:  1996-03-08       Impact factor: 3.046

Review 7.  Cannabinoid pharmacology.

Authors:  W L Dewey
Journal:  Pharmacol Rev       Date:  1986-06       Impact factor: 25.468

8.  Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

Authors:  E Fride; R Mechoulam
Journal:  Eur J Pharmacol       Date:  1993-02-09       Impact factor: 4.432

9.  Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats.

Authors:  A H Lichtman; K R Dimen; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

10.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.

Authors:  M Herkenham; A B Lynn; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  J Neurosci       Date:  1991-02       Impact factor: 6.167

View more
  7 in total

1.  Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice.

Authors:  Graciela N Balerio; Ester Aso; Rafael Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2006-01-14       Impact factor: 4.530

2.  Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.

Authors:  Erica Y Shen; Syed F Ali; Jerrold S Meyer
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

3.  Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice.

Authors:  Lu-lu Yu; Xue-yi Wang; Mei Zhao; Yu Liu; Yan-qin Li; Fang-qiong Li; Xiaoyi Wang; Yan-xue Xue; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

4.  The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.

Authors:  L Robinson; A V Goonawardena; R G Pertwee; R E Hampson; G Riedel
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

5.  Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.

Authors:  Alejandro Aparisi Rey; Martin Purrio; Maria-Paz Viveros; Beat Lutz
Journal:  Neuropsychopharmacology       Date:  2012-08-01       Impact factor: 7.853

6.  Acute Delta 9-tetrahydrocannabinol administration differentially alters the hippocampal opioid system in adult female and male rats.

Authors:  Kyle A Windisch; Sanoara Mazid; Megan A Johnson; Elina Ashirova; Yan Zhou; Lennox Gergoire; Sydney Warwick; Bruce S McEwen; Mary Jeanne Kreek; Teresa A Milner
Journal:  Synapse       Date:  2021-10       Impact factor: 2.537

7.  Chronic nicotine exposure attenuates the effects of Δ9 -tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats.

Authors:  Laurie A Manwell; Tanya Miladinovic; Elana Raaphorst; Shadna Rana; Sarah Malecki; Paul E Mallet
Journal:  Brain Behav       Date:  2019-10-03       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.